JOHN WILEY & SONS, INC. John Wiley & Sons, Inc. Stock Börse Stuttgart
Equities
2F7
US9682232064
Professional Information Services
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.5 EUR | +2.01% |
|
-2.79% | +22.54% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 1.84B 1.7B 2.51B | Sales 2025 * | 1.65B 1.52B 2.25B | Capitalization | 2.11B 1.94B 2.87B |
|---|---|---|---|---|---|
| Net income 2024 * | -191M -176M -260M | Net income 2025 * | 126M 116M 171M | EV / Sales 2024 * | 1.14 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.28 x |
| P/E ratio 2024 * |
-11.1
x | P/E ratio 2025 * |
16.5
x | Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 50.78% |
More Fundamentals
* Assessed data
More news
Latest transcript on John Wiley & Sons, Inc.
More press releases
| 1 week | -2.79% | ||
| Current month | -1.14% | ||
| 1 month | +1.16% | ||
| 3 months | +12.26% | ||
| 6 months | +21.68% | ||
| Current year | +22.54% |
1 week
34.80
36.20
1 month
33.4036.20
3 years
27.0054.00
| Managers | Title | Age | Since |
|---|---|---|---|
Matthew Kissner
CEO | Chief Executive Officer | 70 | 02-12-31 |
Jesse Wiley
CHM | Chairman | 54 | 02-12-31 |
| Director of Finance/CFO | 53 | 21-11-21 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
William Pesce
BRD | Director/Board Member | 73 | 98-04-30 |
George Bell
BRD | Director/Board Member | 67 | 14-08-31 |
Ray McDaniel
BRD | Director/Board Member | 66 | 04-12-31 |
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 35.2 | +1.15% |
| 24-05-16 | 34.8 | 0.00% |
| 24-05-15 | 34.8 | -0.57% |
| 24-05-14 | 35 | -1.69% |
| 24-05-13 | 35.6 | -1.66% |
Delayed Quote Börse Stuttgart, May 17, 2024 at 02:01 am
More quotes
John Wiley & Sons, Inc. is a knowledge company. The Company is engaged in providing research, publishing, and knowledge solutions. The Company's segments include Research, Learning, and Held for Sale or Sold. Research segment is a provide peer-reviewed scientific, technical, and medical (STM) publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. The Learning segment provides scientific, professional, and education print and digital books, digital courseware to libraries, corporations, students, professionals, and researchers, as well as assessment services to businesses and professionals. The Company's Research Publishing products provide scientific, technical, medical, and scholarly journals, as well as related content and services, to academic, corporate, and government libraries, learned societies, and individual researchers, and other professionals.
Calendar
2024-06-12
- Q4 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
38.51
USD
Average target price
50
USD
Spread / Average Target
+29.84%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +20.28% | 77.08B | |
| -12.22% | 39.41B | |
| +13.99% | 37.93B | |
| +0.53% | 30.9B | |
| -6.70% | 16.98B | |
| +14.36% | 15.31B | |
| +9.23% | 10.56B | |
| -9.70% | 4.73B | |
| -34.77% | 4.13B |
- Stock Market
- Equities
- WLY Stock
- 2F7 Stock
